Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Managing Patients With AAV in the Rheumatology Clinic
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Vallerie V. McLaughlin, MD
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
Robert P. Frantz, MD, FACC
Sonja Bartolomei, MD
Pulmonary Hypertension Management: Practice Trends and Updates
Victor Moles, MD
Ioana Preston, MD
Pulmonary Hypertension: Comorbidities With PAH and Group 2 PH
Thomas Cascino, MD
Bradley A. Maron, MD
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
ns-MRAs and eGFR Slope: The Kidney Perspective
FCS and SHTG: Are We Meeting the Need?
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie Ballantyne, MD
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Mastering MRA Monitoring: The Key to Success
Clinical choices in managing LDL-c: Where do novel therapies fit in?
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.